Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Nitric Oxide and Saponin

supplement:

Saponin

Research Papers that Mention the Interaction

Saponin , essential oil and flavonoids could dose-dependently inhibit NO production in LPS-induced RAW 264.7 macrophages, whose inhibition rates were 65.4%, 73.0% and 80.4% at concentration of 50 μg/ml, respectively.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association  •  2019  |  View Paper
SF clearly suppressed the release of nitric oxide (NO) and tumor necrosis factor (TNF)-α, but not prostaglandin E2 (PGE2).
Archives of pharmacal research  •  2009  |  View Paper
Nitric oxide concentrations were increased by the treatment of crude saponin in conscious rats as well as in the cultured ECV 304 cells.
Acta pharmacologica Sinica  •  2000  |  View Paper
Akebia saponin D significantly decreased NO production and iNOS expression.
European journal of pharmacology  •  2019  |  View Paper
The production of nitric oxide and cytokines, induced by adipocyte-conditioned medium (3T3-CM), was significantly decreased by SF.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie  •  2018  |  View Paper
From this extract, eight compounds [two naphthofuranoxepins (1, 2), one phenanthraquinone (3), three steroids (4-6) and two steroidal saponins (7, 8)] were isolated and further investigated for their inhibitory properties of NO production.
Journal of ethnopharmacology  •  2007  |  View Paper
6 L‐NAME and saponin also inhibited 5‐HT, ACh and substance P‐induced NO release (P < 0.05), without affecting equivalent responses to SNP.
Saponin (three cycles of 2 min of 30 μg … 2 min control perfusion) reduced basal coronary NO content by a similar amount (307 ± 22 pmol min−1 g−1) but reduced basal coronary … ± 0.2 ml min−1 g−1 (P < 0.05 versus the effect of L‐NAME).
British journal of pharmacology  •  1996  |  View Paper